Chargeurs Valuation
Is 0E1Y undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0E1Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0E1Y (€10.16) is trading below our estimate of fair value (€46.5)
Significantly Below Fair Value: 0E1Y is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0E1Y?
Key metric: As 0E1Y is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0E1Y's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | €682.90m |
| Market Cap | €238.34m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.8x |
| Enterprise Value/EBITDA | 11.6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0E1Y's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
DCC DCC | 0.3x | 2.4% | UK£5.4b |
SMIN Smiths Group | 1.9x | 4.0% | UK£5.8b |
CEPS CEPS | 0.2x | n/a | UK£4.7m |
LUCE Luceco | 0.9x | 8.2% | UK£202.0m |
0E1Y Chargeurs | 0.3x | 9.7% | €238.3m |
Price-To-Sales vs Peers: 0E1Y is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does 0E1Y's PS Ratio compare vs other companies in the European Industrials Industry?
| 7 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 7 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: 0E1Y is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Industrials industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is 0E1Y's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: 0E1Y is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €10.16 | €13.26 +30.5% | 12.9% | €16.00 | €11.00 | n/a | 5 |
| Nov ’25 | €9.44 | €13.26 +40.5% | 12.9% | €16.00 | €11.00 | n/a | 5 |
| Oct ’25 | €11.54 | €13.26 +14.9% | 12.9% | €16.00 | €11.00 | n/a | 5 |
| Sep ’25 | €12.20 | €13.14 +7.7% | 12.8% | €16.00 | €11.00 | n/a | 5 |
| Aug ’25 | €10.54 | €12.95 +22.9% | 12.3% | €16.00 | €11.00 | n/a | 6 |
| Jul ’25 | €9.36 | €12.67 +35.4% | 13.5% | €16.00 | €10.00 | n/a | 7 |
| Jun ’25 | €13.02 | €12.67 -2.7% | 13.5% | €16.00 | €10.00 | n/a | 7 |
| May ’25 | €11.78 | €12.58 +6.8% | 14.6% | €16.00 | €10.00 | n/a | 6 |
| Apr ’25 | €11.96 | €12.58 +5.2% | 14.6% | €16.00 | €10.00 | n/a | 6 |
| Mar ’25 | €11.98 | €12.58 +5.0% | 14.6% | €16.00 | €10.00 | n/a | 6 |
| Feb ’25 | €11.90 | €12.40 +4.2% | 15.8% | €16.00 | €10.00 | n/a | 5 |
| Jan ’25 | €11.68 | €12.40 +6.2% | 23.1% | €17.00 | €9.00 | n/a | 5 |
| Dec ’24 | €8.53 | €12.33 +44.6% | 29.1% | €18.00 | €7.00 | n/a | 6 |
| Nov ’24 | €7.53 | €15.52 +106.1% | 26.1% | €20.00 | €9.00 | €9.44 | 6 |
| Oct ’24 | €8.07 | €15.52 +92.3% | 26.1% | €20.00 | €9.00 | €11.54 | 6 |
| Sep ’24 | €11.53 | €17.80 +54.4% | 13.8% | €20.00 | €13.00 | €12.20 | 6 |
| Aug ’24 | €11.10 | €19.88 +79.2% | 22.0% | €26.00 | €13.00 | €10.54 | 6 |
| Jul ’24 | €11.08 | €19.88 +79.5% | 22.0% | €26.00 | €13.00 | €9.36 | 6 |
| Jun ’24 | €12.21 | €21.86 +79.1% | 16.2% | €26.00 | €16.50 | €13.02 | 5 |
| May ’24 | €14.88 | €22.80 +53.2% | 14.5% | €26.00 | €16.50 | €11.78 | 5 |
| Apr ’24 | €15.51 | €22.80 +47.0% | 14.5% | €26.00 | €16.50 | €11.96 | 5 |
| Mar ’24 | €14.28 | €23.00 +61.1% | 8.1% | €25.00 | €20.00 | €11.98 | 4 |
| Feb ’24 | €15.27 | €23.00 +50.6% | 8.1% | €25.00 | €20.00 | €11.90 | 4 |
| Jan ’24 | €14.09 | €21.60 +53.3% | 15.1% | €25.00 | €16.00 | €11.68 | 5 |
| Dec ’23 | €12.99 | €21.60 +66.3% | 15.1% | €25.00 | €16.00 | €8.53 | 5 |
| Nov ’23 | €13.41 | €24.76 +84.7% | 18.9% | €29.00 | €16.00 | €7.53 | 5 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
IMI
UK£4.4b
An engineering company, engages in the design, manufacturing, and servicing of engineering products in the United Kingdom, Germany, rest of Europe, the United States, rest of the Americas, China, rest of the Asia Pacific, the Middle East, and Africa.
IMI
UK£17.23
7D
-1.5%
1Y
10.0%
Aalberts
€3.9b
Offers mission-critical technologies for aerospace, automotive, building, and maritime sectors.
0NX1
€35.21
7D
-0.2%
1Y
-2.7%
Rieter Holding
CHF 406.5m
Supplies systems for manufacturing yarn from staple fibers in spinning mills in Switzerland and internationally.
0QKA
CHF 90.50
7D
-1.8%
1Y
5.7%